Cargando…
Larval Zebrafish Model for FDA-Approved Drug Repositioning for Tobacco Dependence Treatment
Cigarette smoking remains the most preventable cause of death and excess health care costs in the United States, and is a leading cause of death among alcoholics. Long-term tobacco abstinence rates are low, and pharmacotherapeutic options are limited. Repositioning medications approved by the U.S. F...
Autores principales: | Cousin, Margot A., Ebbert, Jon O., Wiinamaki, Amanda R., Urban, Mark D., Argue, David P., Ekker, Stephen C., Klee, Eric W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962344/ https://www.ncbi.nlm.nih.gov/pubmed/24658307 http://dx.doi.org/10.1371/journal.pone.0090467 |
Ejemplares similares
-
Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer
por: Yoon, Sungpil, et al.
Publicado: (2021) -
zfishbook: connecting you to a world of zebrafish revertible mutants
por: Clark, Karl J., et al.
Publicado: (2012) -
Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
por: Afzaal, Hasan, et al.
Publicado: (2022) -
FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023) -
Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)